If, after 6 months of thyroxine therapy, TSH levels decline but PRL levels remain elevated, accompanied by persistent amenorrhea, galactorrhea, and no reduction in pituitary size, a pituitary PRL adenoma should be suspected (16). This evidence concerns the gene PRL and Galactorrhea.